Govt aims to boost pharma exports

Published November 13, 2020
Pakistan has finally decided to capitalise on the opportunity created due to Covid-19 pandemic and is aiming to increase pharma exports by $1 billion annually to $5bn in five years. — AFP/File
Pakistan has finally decided to capitalise on the opportunity created due to Covid-19 pandemic and is aiming to increase pharma exports by $1 billion annually to $5bn in five years. — AFP/File

ISLAMABAD: Pakistan has finally decided to capitalise on the opportunity created due to Covid-19 pandemic and is aiming to increase pharma exports by $1 billion annually to $5bn in five years.

“Since the pandemic, we have started manufacturing and exporting Remdesivir injections. Moreover, demand for medicines and personal protective equipment has increased across the globe, and we are exporting these items,” Drug Reg­ulatory Authority of Pakistan (Drap) CEO Dr Asim Rauf said while talking to Dawn.

He said a plant of one of the pharmaceutical companies in Pakistan received US Food and Drug Administration (FDA) approval and hoped that more companies will get the authority’s approval.

Dr Asim said that during the last one year, pharma exports of the country have increased from $200 million to $300m.

“The global community has started trusting Pakistan since the World Health Organisation has trained our Drug Inspectors and arranged training sessions for the industry. This has improved quality of Pakistani drugs. Moreover, Prime Minister Imran Khan is also eager about pharma exports,” he said. Dr Asim claimed that soon manufacturing of Active Pharma­ceutical Ingredients (APIs) will begin in the country. “Pakistan’s import bill will go down and we can also start exporting APIs,” he added.

Talking to Dawn, Pakistan Pharmaceutical Manufacturers’ Association (PPMA) Chairman Tauqeer ul Haq said, “If some facilities are given to the pharma industry, we can deliver much better as compared to textile industry. We demand that import duty on plants and equipment should be zero-rated and relaxation in GST so the industry could import machinery and get it registered with the FDA.

Published in Dawn, November 13th, 2020

Opinion

Between boom and bust
Updated 24 Jun 2021

Between boom and bust

Ultimately the budget, and its aim to pump growth, will be left standing on two legs only — free oil and free dollars from abroad.
Judging without law
Updated 24 Jun 2021

Judging without law

The Supreme Court has yet to formulate a detailed procedure to conduct cases having far-reaching impacts on people’s lives.
Cold war II
23 Jun 2021

Cold war II

China and the West must find a better way.

Editorial

PM on Afghanistan
Updated 24 Jun 2021

PM on Afghanistan

Points raised by PM need to be pondered by all sides — specifically Afghan govt and Taliban — if a civil war is to be avoided.
24 Jun 2021

Third-party interest

WHAT should be done when third-party interest has been created where construction has been done illegally? It is an...
24 Jun 2021

Electricity policy

THE Council of Common Interests has unanimously approved the National Electricity Policy 2021 that will focus on...
PM’s views on rape
Updated 23 Jun 2021

PM’s views on rape

Rape is a crime primarily of power rather than lust, rooted in a contempt for others’ bodily integrity.
23 Jun 2021

Gas concerns

CONSUMERS face the prospect of ominous blackouts next month owing to the closure of two gas fields in Sindh, the ...
23 Jun 2021

New Iranian president

SAYYID Ebrahim Raisi, Iran’s new president, is taking over at a time of great geopolitical flux, while the Islamic...